Breakthrough First-in-Class Covalent Werner Helicase Inhibitor Demonstrates Clinical Proof-of-Concept in Phase I Trial
In a landmark development in the field of oncology and targeted cancer therapies, researchers at The University of Texas MD ...
In a landmark development in the field of oncology and targeted cancer therapies, researchers at The University of Texas MD ...
In the rapidly evolving landscape of molecular biology, R-loops—a three-stranded nucleic acid structure formed by an RNA:DNA hybrid and a ...
Insilico Medicine, a pioneering biotechnology company specializing in generative artificial intelligence (AI), has recently made significant strides in cancer treatment. ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine